Myeloperoxidase (pANCA) - 1.0mg

Myeloperoxidase (pANCA) - 1.0mg

Regular price
$1,206.67
Regular price
Sale price
$1,206.67
Unit price
per 
Availability
Sold out

Myeloperoxidase (pANCA)


pANCA antigen
Uniprot ID:  P05164
mRNA RefSeq:  NM_000250
Protein RefSeq:  NP_000241
Size: 1.0mg
Source: Human Neutrophils

 

Product Information:

Autoantibodies staining the nuclei or the perinuclear zone of neutrophils by indirect immunofluorescence are referred to as pANCA whereas those giving a clear cytoplasmic fluorescence are referred to as cANCA. The antigen recognised by most pANCA sera has been identified as myeloperoxidase.

Autoantibodies to MPO are found in the sera of patients with various types of systemic vasculitis including idiopathic crescentic glomerulonephritis, Churg-Strauss syndrome, microscopic polyangiitis and polarteritis nodosa. Anti-myeloperoxidase antibodies have also been reported in some patients with Wegener's granulomatosis, and occasionally in patients with rheumatoid arthritis or inflammatory bowel disease.

The heme-containing glycoprotein myeloperoxidase is a major constituent of neutrophil azurophilic granules and plays a major role in the oxygen-dependent microbicidal system of these cells. This enzyme catalyses the oxidation of chloride by hydrogen peroxide to produce the highly reactive reagent hypochlorous acid.

When isolated from mature neutrophil granulocytes, myeloperoxidase consists of a tetramer composed of two 59 kDa and two 12 kDa subunits that are evident under reducing SDS-electrophoresis. Myeloperoxidase cDNA has been cloned and sequenced, revealing that the protein is synthesised as an 80 kDa precursor before it is processed into the 59 and 12 kDa subunits of 467 and 113 amino acids respectively.

Autoantibodies to MPO appear to recognise conformational epitopes. The use of purified myeloperoxidase for the detection of anti-myeloperoxidase autoantibodies by solid-phase ELISA has been described by several authors.

 PDF-logo-dl Myeloperoxidase (pANCA) datasheet


Clinical Indications: 

Idiopathic Crescentic Glomerulonephritis
Churg-Strauss syndrome
Microscopic Polyangiitis
Polyarteritis Nodosa
Elevated plasma levels in acute coronary syndromes and some malignant

MSDS:

PDF-logo-dl  Material Safety Data Sheet


References:

Davies, D.J. et al. (1982) Br. Med. J. 285, 606

Wiik, A. et al. (1994) Man. Biol. Markers of Dis. (Kluwer Acad.Publ.) A9:1-14

Falk, R.J. & Jennette, J.C. (1988) N. Engl. J. Med. 316, 1651

Falk, R.J. et al. (1990) Neth. J. Med. 36, 121-125

Lee, S.S. et al. (1990) Clin. Exp. Immunol. 79, 41-46

Cohen Tervaert, R. et al. (1990) Arthr. Rheum. 33, 1264

Gueirard, P. et al. (1991) J. Autoimmun. 4, 517

Ulmer, M. (1992) Clin. Nephrol. 37, 161

Kallenberg, C.G.M. et al. (1994) Kidney Int. 46, 1

Cambridge, G. et al. (1994) Ann. Rheum. Dis. 53, 241

Snook, J.A. (1989) Clin. Exp. Immunol. 76, 301

Klebanoff, S.J. (1968) J. Bacteriol. 95, 21311

Harrison, J.E. & Schultz, J. (1976) J. Biol. Chem. 251, 13711

Olsen, R.L. & Little, C. (1984) Biochem. J. 222, 7011

Falk, R.J. et al. (1992) Clin. Exp. Immunol. 89, 274